1 of 3

NEW EIS DEAL

CamGraPhIC EIS

Cambridge University spinout commercialising graphene photonics technology for 5G – endorsed by major Telcos

Read more and apply online

2 of 3

NOW OPEN

Northern VCTs

A better deal than going direct: up to 2.75% initial saving plus 0.10% annual rebate

Read more and apply online

3 of 3

EXCLUSIVE

Private equity

What is the appeal of private equity? How does it work? How can it be accessible to private investors? What are the risks?

Read more and get free guide

Wealth Club is the UK’s largest service of its kind for high net worth and sophisticated investors

Read about Wealth Club
£325m

VCT tax-free dividends paid (2019/20)

£1.45bn

Amount EIS investors claimed income tax relief on (2019/20)

£2.22bn

Amount protected from IHT through BPR (2017/18)

Featured offers

Our favourite current opportunities: investments we think have genuine merit, whose managers we believe can deliver returns to investors. Read more.

VCT

View all VCT offers

EIS

View all EIS offers

SEIS

View all SEIS offers

IHT

View all IHT offers

AIM ISA

View all AIM ISA offers

Latest News. Read all

Private equity: finally accessible to private investors?

25 November 2021

Those allowed to invest, historically institutional investors or the ultra-wealthy, have been well rewarded. Private equity funds overall have consistently outperformed their public market equivalents over the last 15, 20 and 25 years. Note, past performance ...

A new investment opportunity – 26 years in the making

9 November 2021

I have been an investor most of my life. Throughout the years, some of the most pleasing performance has come from smaller companies funds.The Marlborough Special Situations Fund has been a particular highlight. Until recently, it ...

Top 10 most viewed pages

17 January 2022

Which offers are attracting investors’ interest? Every Monday we look at the offers Wealth Club members have viewed on our website the previous week. Then we compile the top ten across the different types of investment: ...

Video of the week

Founder & CEO interview: Solascure EIS

We talk to Dr Sam Bakri, founder and CEO of biotech company Solascure, to talk about their EIS investment opportunity, which closes on 28 January (or earlier, if filled).

What is the market opportunity, what are the risks, and what kind of returns and timescale does the company hope to offer investors? Watch our interview with Dr Bakri to learn more.